Are Dividend Aristocrats Worth It? A Filter, Not a Buy Signal

Dividend Aristocrats are worth a place on your shortlist and no place on your buy list. The label is a good filter: it removes every company that has cut, frozen or skipped its dividend in the last 25 years, which is most of the market. It is a poor buy signal, because the streak says nothing about today's price, the share of profit already going out the door, or whether the last ten raises were 8 percent or 1 percent.

The verdict, in one line: start from the list, then do the work you would have done anyway. An Aristocrat that passes the safety checks at a yield above its own average is a fine purchase. An Aristocrat bought because it is an Aristocrat is a bet that the past repeats at whatever price the market asks.

What the list criteria actually are

The S&P 500 Dividend Aristocrats index belongs to S&P Dow Jones Indices and has fixed rules. A company qualifies when it is in the S&P 500, has raised its dividend for at least 25 consecutive years, and clears a size and liquidity floor (a float-adjusted market value of a few billion dollars and a minimum daily trading value). The index holds at least 40 names, equally weighted, and checks membership every January.

The Dividend Kings are a different kind of thing. The bar is 50 consecutive years of increases, but no index provider owns the label, there is no size floor and no S&P 500 requirement. Publishers compile the lists and disagree at the margins; about 50 US companies qualify, many of them small.

The word Aristocrat is the same in every row. The standard is not.

What a 25-year streak proves

A streak that long is real evidence, and it is worth being precise about what it is evidence of. It proves the board treats the dividend as a commitment rather than a residual: 25 years of raises covers at least two recessions, so the company found the cash to raise the payout while profits were falling. It proves the business survived those recessions without a rescue that wiped out shareholders. And it proves that management inherited something they would rather not be the ones to break, which is why streaks tend to run on: the incentive to reach year 26 is stronger than the incentive to reach year 3.

What the streak does not prove

It says nothing about valuation. A company with a 30-year streak can trade at 35 times earnings and a 1.5 percent yield, and often does, because everyone else has read the same list. The streak says the dividend is reliable, not that it is worth buying at this price.

It says nothing about the payout ratio. A streak can be kept alive while the share of profit paid out drifts from 40 percent to 90 percent. The raises continue until the year they cannot, and the list reacts only after the cut.

It says nothing about the pace of the raises. A raise of one cent a share counts as much as a raise of 10 percent, and a company that raises below inflation for years pays you less in real terms while the label says the opposite.

And it says nothing about the future. The next 25 years belong to the balance sheet, the cash flow and the industry, and the label measures none of them.

How Aristocrats fail

The token raise. When earnings stall, a board that values the streak raises the dividend by the smallest amount that still counts: 1 percent a year, sometimes less. The company stays on the list, the payout ratio climbs, and the investor who bought for growing income gets a payout that grows slower than the grocery bill.

The cut, and the exit. The list is rewritten after the damage. In 2009 the financials left in a group: banks that had raised for decades cut or suspended within months, along with a large industrial conglomerate and a drugmaker that halved its payout. In 2020 the exits included an oil driller and a retailer that suspended its dividend while its stores were closed. In every case the streak was intact the year before, and the payout ratio and cash flow cover had been signalling trouble for a year or more.

The price you pay. Because the list is popular, its members are rarely cheap in a calm market. Buying Aristocrats when their yields sit well below their own history means paying for safety that is already priced in, and the return from that starting point tends to be modest even when every dividend arrives.

Do Dividend Aristocrats outperform?

Not reliably. Over long periods the Aristocrats index has tended to fall less than the S&P 500 in downturns and lag it in strong bull markets, particularly the ones led by technology companies that pay little or nothing. Add the two halves together and the long-run result has been close to the broad index, with lower volatility and a smoother path.

That is a respectable outcome, but it is not outperformance, and it is not free: the price of the smoother ride is the years when the market runs and the Aristocrats walk. When a chart shows the Aristocrats winning by a wide margin, check the start date.

The European versions are a different standard

European readers meet the word Aristocrat on the SPDR ETFs, and the lists behind those funds are built to a lower bar. The S&P Europe 350 Dividend Aristocrats need ten consecutive years of a dividend raised or at least held, not 25 years of raises. The UK version uses the same ten-year rule, and the Canadian one accepts five. A ten-year window does not reach back to 2008, so a European Aristocrat has been tested by one downturn, not two, and a held dividend passes where a US one would not.

Three local details matter. Most European companies pay once or twice a year, so a hold costs nothing in streak terms. In 2020 the European Central Bank and the UK regulators told banks and insurers to suspend dividends outright, which broke streaks that had nothing to do with the health of the business. And the Swiss names with the longest records count their streaks in francs, so a euro or sterling investor sees a different growth rate after currency moves.

The practical rule: treat ten years as a first cut, and apply the 25-year test yourself by reading the history back to 2008.

How to use the list

1. Start from the list to shorten the field. The Aristocrats give you about 70 names, the Kings about 50, the European lists a few dozen each: a set you can actually research.
2. Run the safety checks on each one: a payout ratio between 40 and 60 percent of earnings, free cash flow that covers the dividend with room to spare, net debt under about two times EBITDA for an ordinary business, and five-year dividend growth of at least 5 percent. A member that fails two of these is about to stop being one.
3. Wait for the price. Compare the current yield with the company's own five-year average. Near or above it, the market is not charging a premium for the label today. Well below it, you are paying one. The list barely changes from year to year; the prices do.
4. Re-check after every set of results. The streak updates once a year; the payout ratio, cash flow and debt update every quarter, and they move first.

Follow those steps and the list stops mattering much, which is the point. The label got the name in front of you. The numbers decided.

The ETF route

If picking through 70 names is more than you want, the index is available as a fund. The US-listed ProShares fund tracks the S&P 500 Aristocrats directly, but most European brokers cannot sell it to retail investors because it lacks the required key information document. The Irish-domiciled SPDR range covers the US, European, UK and global lists; its US fund uses a 20-year rule over a wider universe, so read the fact sheet before assuming it holds the same names. An Irish-domiciled fund suffers 15 percent US withholding inside the fund on its US stocks and pays non-residents without a further deduction, usually the cheaper structure for a European holder. The trade-off is that the fund buys every member at whatever the price is, so step three above is done for you, not in your favour.

Keeping the checks running

The hard part is re-running the payout ratio, cash flow cover and yield checks after every results season, across every Aristocrat you hold and every one you are waiting to buy. A portfolio tracker such as Cadances carries those checks on each ticker: the Dividend Kings one-click screen on the Screener lists the longest streaks with a 0 to 100 dividend safety score beside each, the screener sets floors on payout ratio and five-year dividend growth, and every holding's page shows the fundamentals and the raises or cuts as they land. The list tells you where to look; the tracker tells you when a name on it has stopped deserving the label.

Questions people ask

What are the Dividend Aristocrats list criteria?

Membership of the S&P 500, at least 25 consecutive years of dividend increases, and minimum size and liquidity floors. The index is equal weighted and reviews membership every January; a company that fails to raise, or leaves the S&P 500, drops out.

Dividend Kings vs Aristocrats: what is the difference?

Kings need 50 consecutive years of increases, twice the Aristocrat bar, but the Kings are a publisher's list rather than an S&P index, with no size floor and no S&P 500 requirement. Many Kings are small companies.

Are there European Dividend Aristocrats?

Yes, under a different rule. The S&P Europe 350 and S&P UK Dividend Aristocrats need only ten years of raised or held dividends, a much lower test than the US one. Read the history back to 2008 before treating the label as equivalent.

Which Dividend Aristocrats ETF should a European investor buy?

The Irish-domiciled SPDR Aristocrats range is the practical choice for most eurozone, UK and Swiss investors, because the US-listed ProShares fund is usually not available to European retail accounts. Check which index the fund tracks, since the US version uses a 20-year rule.

Do Dividend Aristocrats outperform the S&P 500?

Over long periods the result has been close to the index with lower volatility: the Aristocrats have tended to lose less in downturns and lag in strong bull markets. Whether they win over a given window depends mostly on where the window starts.